Krishna Institute Peer Comparison

NSE: KIMS | BSE: 543308

₹736.25

₹-10.15 (-1.36%)

As on 01-Oct-2026IST

Market cap

₹30,875 Cr

Revenue (TTM)

₹4,213 Cr

P/E Ratio

151.1

P/B Ratio

8.2

Div. Yield

0 %

Edit

	Krishna Institute	Global Health	Dr. Lal Pathlabs	Vijaya Diagno	Metropolis Health
Market cap (₹ Cr)	30,875	36,515	33,680	14,713	11,161
Revenue (₹ Cr)	4,213	4,683	2,891	857	1,710
Net Profit (₹ Cr)	190.80	552.34	546.30	187.49	202.82
Net Margin (%)	4.49	11.55	18.23	21.32	11.70
RoE (%)	9.45	14.93	23.03	20.58	14.13
Price to Earnings	151.12	65.65	62.15	78.47	55.36
Price-To-Book	8.16	8.88	12.89	14.61	7.16

Income Statement (₹ Cr)

	Krishna Institute	Global Health	Dr. Lal Pathlabs	Vijaya Diagno	Metropolis Health
Operating Revenue	4,212.50	4,683.37	2,890.80	857.13	1,710.00
Total Income	4,248.00	4,783.78	2,995.90	879.41	1,733.17
Total Expenditure	3,379.70	3,704.62	2,053.10	495.19	1,287.72
EBITDA	832.80	978.75	837.70	361.94	422.28
Depreciation	330.60	246.41	171.60	96.06	135.28
EBIT	502.20	732.34	666.10	265.89	287.00
Interest	253.30	92.01	24.40	36.75	25.53
Other Income	35.50	100.41	105.10	22.28	23.17
Exceptional Items	-11.20	-20.61	-30.10	0.00	-8.99
Profit before Tax	273.20	720.14	716.70	251.42	275.66
Provision for Tax	82.40	167.80	170.40	63.93	72.84
Profit after Tax	190.80	552.34	546.30	187.49	202.82

	Krishna Institute	Global Health	Dr. Lal Pathlabs	Vijaya Diagno	Metropolis Health
Shareholder's Funds	2,247.40	3,961.57	2,508.20	957.15	1,513.16
Minority Interest	9.90	3.84	-4.40	0.00	-1.20
Non-Current Liabilities	3,961.30	1,293.60	154.00	426.03	279.48
Current Liabilities	1,238.90	627.13	450.70	123.87	334.02
Total Liabilities	7,690.70	5,905.00	3,139.97	1,507.05	2,524.76

	Krishna Institute	Global Health	Dr. Lal Pathlabs	Vijaya Diagno	Metropolis Health
Non-Current Assets	5,416.90	3,128.95	1,176.30	737.24	1,415.30
Current Assets	937.40	1,674.92	1,566.60	321.90	468.61
Total Assets	7,690.70	5,905.00	3,139.97	1,507.05	2,524.76
Total Debt*	3,244.00	631.08	0.00	0.00	18.73
Net Current Assets	-301.50	1,047.79	1,115.90	198.03	134.59
Contingent Liabilities	81.10	100.01	16.76	0.13	10.08

	Krishna Institute	Global Health	Dr. Lal Pathlabs	Vijaya Diagno	Metropolis Health
Cash From Operating Activities	510.80	714.39	635.61	270.59	350.70
Cash Flow from Investing Activities	-1,451.70	-1,089.11	-421.86	-174.22	-223.13
Cash from Financing Activities	940.30	271.85	-263.57	-69.49	-115.29
Net Cash Inflow / Outflow	-0.60	-102.87	-49.83	26.88	12.28

	Krishna Institute	Global Health	Dr. Lal Pathlabs	Vijaya Diagno	Metropolis Health
ROCE (%)	11.51	19.38	29.56	30.28	20.03
ROE (%)	9.45	14.93	23.03	20.58	14.13
ROA (%)	2.83	10.35	18.64	13.49	10.13
EBIT Margin (%)	11.92	15.64	23.04	31.02	16.78
Net Margin (%)	4.49	11.55	18.23	21.32	11.70
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Krishna Institute	Global Health	Dr. Lal Pathlabs	Vijaya Diagno	Metropolis Health
Revenue Growth (%)	30.90	21.27	14.29	20.18	21.80
EBIT Growth (%)	-16.88	0.94	15.64	26.22	43.53
Net Profit Growth (%)	-52.81	3.43	5.38	24.27	32.87
EPS Growth (%)	-42.60	2.70	-30.51	23.44	-16.64
Book Value Growth (%)	5.13	16.51	15.41	21.86	13.54

	Krishna Institute	Global Health	Dr. Lal Pathlabs	Vijaya Diagno	Metropolis Health
Price / Earnings	139.13	63.76	47.07	78.33	21.86
Price / Book Value	8.16	8.88	12.89	14.61	7.16
Dividend Yield (%)	0.00	0.04	1.02	0.14	0.93
EV/EBITDA	40.86	36.80	38.61	39.87	25.99
Market Cap (₹ Cr)	24,901.98	25,841.07	22,015.15	8,864.05	8,992.90

	Krishna Institute	Global Health	Dr. Lal Pathlabs	Vijaya Diagno	Metropolis Health
Debt to Equity	1.19	0.15	0.00	0.00	0.00
Short term debt to equity ratio	0.15	--	--	--	0.01
Current Ratio	0.76	2.67	3.48	2.60	1.40
Quick Ratio	0.68	2.54	3.38	2.56	1.27
Interest Coverage	2.08	8.83	30.37	7.84	11.80

	Krishna Institute	Global Health	Dr. Lal Pathlabs	Vijaya Diagno	Metropolis Health
Debtors to sales (%)	13.16	8.78	3.83	2.43	9.96
Asset Turnover	0.62	0.88	0.99	0.62	0.85
Receivable days	44.38	29.09	13.13	7.98	35.29
Inventory Days	7.52	6.05	5.28	2.20	10.35
Payable days	133.54	80.04	118.67	136.27	143.56
Cash Conversion Cycle	-81.64	-44.90	-100.26	-126.08	-97.92

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.